Evidence map›Paper›PMID 33529164›Full record

ReviewThe Journal of clinical investigation2021

Monogenic diabetes: a gateway to precision medicine in diabetes.

Haichen Zhang, Kevin Colclough, Anna L Gloyn, Toni I Pollin

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 1 pooled it
26.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 1 synthesis or guideline pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Digenic HNF1A and ABCC8 variants provide mechanistic insight into early-onset diabetes.The Journal of clinical endocrinology and metabolism · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. dentification and characterization of novelBMJ open diabetes research & care · 2025
    Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Haichen ZhangUniversity of Maryland School of Medicine, Department of Medicine, Baltimore, Maryland, USA.
Kevin ColcloughExeter Genomics Laboratory, Royal Devon and Exeter Hospital, Exeter, United Kingdom.
Anna L GloynDepartment of Pediatrics, Division of Endocrinology, and.
Toni I PollinUniversity of Maryland School of Medicine, Department of Medicine, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USRoyal Devon and Exeter Hospital · GBStanford Medicine · US

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes (Administrative Supplment)U01HG007775 · NHGRI · UNIVERSITY OF MARYLAND BALTIMORE · PI POLLIN, TONI I. · 2014 to 2018
$4.3M
Identifying variants causal for Type 2 Diabetes in Major human populationsU01DK085545 · NIDDK · UNIVERSITY OF OXFORD · PI CHAN, JULIANA CN, EBRAHIM, SHAH BRIAN · 2009 to 2013
$2.8M
Integrating genome-scale data to reveal causal mechanisms in type 2 diabetesU01DK105535 · NIDDK · UNIVERSITY OF OXFORD · PI GLOYN, ANNA LOUISE · 2015 to 2019
$1.7M
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes MellitusU24HD093486 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI POLLIN, TONI I. · 2017 to 2019
$816k
NHGRI NIH HHS U01 HG007775NICHD NIH HHS U24 HD093486NIDDK NIH HHS P30 DK116074NIDDK NIH HHS U01 DK085545NIDDK NIH HHS U01 DK105535Wellcome Trust 095101Wellcome Trust 200837Wellcome Trust 200837/Z/16/Z
6 · The paper itself

Abstract

Monogenic diabetes refers to diabetes mellitus (DM) caused by a mutation in a single gene and accounts for approximately 1%-5% of diabetes. Correct diagnosis is clinically critical for certain types of monogenic diabetes, since the appropriate treatment is determined by the etiology of the disease (e.g., oral sulfonylurea treatment of HNF1A/HNF4A-diabetes vs. insulin injections in type 1 diabetes). However, achieving a correct diagnosis requires genetic testing, and the overlapping of the clinical features of monogenic diabetes with those of type 1 and type 2 diabetes has frequently led to misdiagnosis. Improvements in sequencing technology are increasing opportunities to diagnose monogenic diabetes, but challenges remain. In this Review, we describe the types of monogenic diabetes, including common and uncommon types of maturity-onset diabetes of the young, multiple causes of neonatal DM, and syndromic diabetes such as Wolfram syndrome and lipodystrophy. We also review methods of prioritizing patients undergoing genetic testing, and highlight existing challenges facing sequence data interpretation that can be addressed by forming collaborations of expertise and by pooling cases.

Indexed as

Diabetes MellitusHepatocyte Nuclear Factor 1-alphaHepatocyte Nuclear Factor 4MutationPrecision MedicineGenetic Diseases, InbornHumansSulfonylurea CompoundsHepatocyte Nuclear Factor 1-alphaHepatocyte Nuclear Factor 4HNF1A protein, humanHNF4A protein, humanSulfonylurea Compounds

Identifiers

PMID33529164
PMCPMC7843214
OpenAlexW3127261530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.